Aurora Cannabis (TSE:ACB) Stock Rating Upgraded by Atb Cap Markets

Aurora Cannabis (TSE:ACB - Get Free Report) was upgraded by stock analysts at Atb Cap Markets from a "hold" rating to a "strong-buy" rating in a report released on Wednesday, February 5th,Zacks.com reports.

ACB has been the subject of several other research reports. TD Securities raised Aurora Cannabis to a "strong-buy" rating in a report on Thursday, December 12th. ATB Capital decreased their target price on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th. Three equities research analysts have rated the stock with a hold rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Aurora Cannabis currently has a consensus rating of "Moderate Buy" and an average price target of C$7.11.

Aurora Cannabis Price Performance

Shares of ACB traded down C$0.13 during trading hours on Wednesday, hitting C$9.06. The stock had a trading volume of 528,322 shares, compared to its average volume of 663,991. The company's fifty day moving average is C$6.30 and its two-hundred day moving average is C$7.20. The stock has a market capitalization of C$495.22 million, a price-to-earnings ratio of -14.38 and a beta of 2.71. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48. Aurora Cannabis has a 52 week low of C$3.84 and a 52 week high of C$12.85.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.